AGMBAgomAb Therapeutics NV
$9.05
$9.05
$8.1852 weeks$17.57
What is the market doing?
Mixed
1 good, 1 neutral, 1 without dataNo clear lean: nothing decisive, though insiders cluster-buying.
Insider conviction+$400K (90 days to Oct 22, 2026)SEC EDGAR · Oct 22, 2026
Multiple insiders bought with their own money, the strongest form of the signal (the 90 days ending Oct 22, 2026).
Short interest2.9% of sharesFINRA · Sep 30, 2026
Lightly shorted, settled Sep 30, 2026, more than a week of normal trading to cover, a crowded exit.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How AGMB is trading
- Below its 52-week high
- 49%
Below its 52-week high
Details›
- Last close2026-10-23
- $9.05
- 1 monthS&P 500 −0.94%
- −15%
- 52-week high
- $17.57
- 52-week low
- $8.18
- Annualised volatility
- 91%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-22
- $400K
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Biotechnology
The closest names by size in the same industry